Find a Treatment Center

Investor Relations

Contact Us

KiteKonnect®

Newsroom

Recent Press Releases

February 02, 2023
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
January 30, 2023
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma

Recent Company Statements

February 9, 2021
Kite Announces U.S. FDA Clearance of Investigational New Drug Application for KITE-222, an Anti-CLL-1 CAR T-Cell Therapy Candidate for Acute Myeloid Leukemia

Explore More

Media Inquiries

Gilead Newsroom